Fabrics for therapeutic skin care bedding

1. A fabric comprising:

a woven fabric having warp yarns and filling yarns, wherein the warp yarns are about 30 denier to 100 denier, and the filling yarns are about 30 denier to 100 denier, wherein the warp yarns and filling yarns are woven together in a plain weave to provide a pill resistant fabric having identical surfaces on both sides thereof;

one of the warp or filling yarns being 100% continuous filament nylon making up at least 40% by weight of the fabric, wherein all of the filaments therein have round cross sections;

the other of the warp or filling yarns being continuous filament polyester or nylon making up the remainder of the weight of the fabric, wherein all of the filaments therein have non-round cross sections; and

wherein the woven fabric is finished such that the woven fabric has an elongation greater than about 30% as measured in accordance with ASTM D5034-95.

2. The fabric according to claim 1 , wherein the warp yarns are 100% nylon.

3. The fabric according to claim 2 , wherein the filling yarns are 100% polyester.

4. The fabric according to claim 1 , wherein the filling yarns are 100% nylon.

5. The fabric according to claim 1 , wherein an antimicrobial substance is topically applied or inherently available in the fabric.

6. The fabric according to claim 1 , wherein the warp yarn is a 70 denier, 48 filament, textured, continuous filament nylon yarn.

7. The fabric according to claim 1 , wherein the filling yarn is a 75 denier, 36 filament, continuous filament textured polyester.

8. The fabric according to claim 1 , wherein the non-round filament cross sections are star shaped cross sections.

9. The fabric according to claim 1 , wherein the non-round filament cross sections are clover leaf cross sections.

10. The fabric according to claim 1 , wherein the continuous filament warp or filling yarns with non-round filament cross sections are configured such that adjacent filaments form wicking channels.

11. The fabric according to claim 1 , further comprising a soil-release topical finish.

12. A fabric comprising:

a woven fabric having warp yarns and filling yarns woven together in a plain weave to provide a pill resistant fabric having identical surfaces in both sides thereof;

the warp yarns being 100% continuous filament 70 denier, 48 filament, textured nylon yarn making up at least 40% by weight of the fabric, wherein all of the filaments therein have round cross sections;

the filling yarns being up to about 60% by weight of the fabric of continuous filament 75 denier, 36 filament, textured polyester making up the remainder of the weight of the fabric, wherein all of the filaments therein have non-round filament cross sections that are star shaped or clover leaf shaped; and

wherein the woven fabric is finished such that the woven fabric has an elongation greater than about 30% as measured in accordance with ASTM D5034-95.

13. The fabric according to claim 12 , further comprising a soil-release topical finish.

14. A fabric comprising:

a woven fabric having warp yarns and filling yarns woven together in a plain weave to provide a pill resistant fabric having identical surfaces on both sides thereof;

one of the warp or filling yarns being 100% continuous filament nylon making up at least 40% by weight of the fabric, wherein all of the filaments therein have round cross sections;

the other of the warp or filling yarns being continuous filament polyester or nylon and making up the remainder of the weight of the fabric, wherein all of the filaments therein have non-round cross sections; and

wherein the woven fabric is finished such that the woven fabric has an elongation greater than about 30% as measured in accordance with ASTM D5034-95.

15. The fabric according to claim 14 , wherein the fabric has an average Kawabata geometric roughness of less than about 1.7 microns.

16. The fabric according to claim 14 , wherein the fabric has a percent (%) dryness after 1 hour of 100%.

17. The fabric according to claim 14 , wherein the fabric has an antimicrobial efficacy against Escherichia coli, Staphylococcus epidermidis , and Pseudomonas aeruginosa (per AATCC 100) of at least about 99.4%.

18. The fabric according to claim 12 , further comprising an antimicrobial substance topically applied or inherently available in the fabric.

19. A fabric comprising:

a woven fabric having warp yarns and filling yarns, wherein the warp yarns are about 30 denier to 100 denier, and the filling yarns are about 30 denier to 100 denier, wherein the warp yarns and filling yarns are woven together in a plain weave to provide a pill resistant fabric having identical surfaces on both sides thereof;

one of the warp or filling yarns being 100% continuous filament nylon making up at least 40% by weight of the fabric, wherein all of the filaments therein have round cross sections;

the other of the warp or filling yarns being continuous filament polyester or nylon making up the remainder of the weight of the fabric, wherein all of the filaments therein have star shaped cross sections, and wherein the continuous filament warp or filling yarns with star shaped filament cross sections are configured such that adjacent filaments form wicking channels; and

wherein the woven fabric is finished such that the woven fabric has an elongation greater than about 30% as measured in accordance with ASTM D5034-95.

20. The fabric according to claim 19 , wherein the warp yarns are 100% nylon.

21. The fabric according to claim 20 , wherein the filling yarns are 100% polyester.

22. The fabric according to claim 19 , wherein the filling yarns are 100% nylon.

23. The fabric according to claim 19 , wherein an antimicrobial substance is topically applied or inherently available in the fabric.

24. The fabric according to claim 19 , wherein the warp yarn is a 70 denier, 48 filament, textured, continuous filament nylon yarn.

25. The fabric according to claim 19 , wherein the filling yarn is a 75 denier, 36 filament, continuous filament textured polyester.

26. The fabric according to claim 19 , further comprising a soil-release topical finish.

27. A fabric comprising:

a woven fabric having warp yarns and filling yarns, wherein the warp yarns are about 30 denier to 100 denier, and the filling yarns are about 30 denier to 100 denier, wherein the warp yarns and filling yarns are woven together in a plain weave to provide a pill resistant fabric having identical surfaces on both sides thereof;

one of the warp or filling yarns being 100% continuous filament nylon making up at least 40% by weight of the fabric, wherein all of the filaments therein have round cross sections;

the other of the warp or filling yarns being continuous filament polyester or nylon making up the remainder of the weight of the fabric, wherein all of the filaments therein have clover leaf shaped cross sections, and wherein the continuous filament warp or filling yarns with clover leaf shaped filament cross sections are configured such that adjacent filaments form wicking channels; and

wherein the woven fabric is finished such that the woven fabric has an elongation greater than about 30% as measured in accordance with ASTM D5034-95.

28. The fabric according to claim 27 , wherein the warp yarns are 100% nylon.

29. The fabric according to claim 28 , wherein the filling yarns are 100% polyester.

30. The fabric according to claim 27 , wherein the filling yarns are 100% nylon.

31. The fabric according to claim 27 , wherein an antimicrobial substance is topically applied or inherently available in the fabric.

32. The fabric according to claim 27 , wherein the warp yarn is a 70 denier, 48 filament, textured, continuous filament nylon yarn.

33. The fabric according to claim 27 , wherein the filling yarn is a 75 denier, 36 filament, continuous filament textured polyester.

34. The fabric according to claim 27 , further comprising a soil-release topical finish.